TABLE 3.
AdNull | AdhApoE3 | |||
Control | Probucol | Control | Probucol | |
Plasma | ||||
Total cholesterol (mg/dl) | 72.3 ± 1.7 | 35.3 ± 1.3a | 63.7 ± 2.8 | 21.9 ± 1.3a |
Free cholesterol (mg/dl) | 22.2 ± 0.4 | 10.7 ± 0.6a | 29.8 ± 2.0 | 8.5 ± 1.1a |
Esterified cholesterol (mg/dl) | 50.1 ± 1.8 | 24.6 ± 1.1a | 34.0 ± 2.0 | 13.4 ± 0.6a |
Phospholipids (mg/dl) | 154.1 ± 7.4 | 97.7 ± 5.8a | 137.8 ± 9.5 | 59.8 ± 1.3a |
Triglycerides (mg/dl) | 58.2 ± 7.1 | 36.0 ± 3.5a | 95.3 ± 7.9 | 32.4 ± 7.0a |
Liver | ||||
Total cholesterol (nmol/mg liver) | 7.2 ± 0.2 | 7.5 ± 0.2 | 9.1 ± 0.4 | 9.2 ± 0.5 |
Free cholesterol (nmol/mg liver) | 5.9 ± 0.1 | 6.0 ± 0.2 | 7.4 ± 0.5 | 6.9 ± 0.3 |
Esterified cholesterol (nmol/mg liver) | 1.3 ± 0.1 | 1.5 ± 0.1 | 1.7 ± 0.2 | 2.3 ± 0.2 |
Phospholipids (nmol/mg liver) | 29.2 ± 0.7 | 26.5 ± 0.6a | 26.7 ± 0.6 | 27.8 ± 0.6 |
Triglycerides (nmol/mg liver) | 21.4 ± 1.7 | 22.3 ± 3.3 | 63.7 ± 7.1 | 59.4 ± 8.6 |
Bile | ||||
Bile flow (μl/min/100 g bw) | 9.3 ± 0.6 | 8.2 ± 0.7 | 7.3 ± 1.1 | 10.6 ± 0.9 |
Biliary bile acid secretion (nmol/min/100 g bw) | 469 ± 90 | 357 ± 73 | 427 ± 81 | 466 ± 51 |
Biliary phospholipid secretion (nmol/min/100 g bw) | 41.6 ± 3.1 | 37.7 ± 5.6 | 43.0 ± 5.4 | 64.3 ± 5.1a |
Biliary cholesterol secretion (nmol/min/100 g bw) | 3.5 ± 0.4 | 3.6 ± 0.5 | 2.9 ± 0.4 | 5.2 ± 0.7a |
Mice were fed a control chow diet or a chow diet containing 0.5% probucol for 2 weeks. On day 4 after adenovirus injection, bile was collected continuously for 30 min, plasma samples were taken, and livers were harvested and snap-frozen in liquid nitrogen. Plasma lipids, liver lipids, and biliary output rates of bile acids, phospholipids, and cholesterol were determined as described in Materials and Methods. Values are means ± SEM; n = 6 mice for each condition. AdhApoE3, recombinant adenovirus expressing human apoE3; AdNull, empty control adenovirus; bw, body weight.
Significantly different from the respective controls as assessed by Mann-Whitney U-test (at least P < 0.05).